TEVA PHARMACEUTICAL FINANCE NETHERLANDS III B.V., as Issuer, TEVA PHARMACEUTICAL INDUSTRIES LIMITED, as Guarantor, and THE BANK OF NEW YORK MELLON, as Trustee SECOND SUPPLEMENTAL SENIOR INDENTURE Dated as of November 25, 2019 to the Senior Indenture...Second Supplemental Senior Indenture • November 25th, 2019 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
Contract Type FiledNovember 25th, 2019 Company Industry JurisdictionSECOND SUPPLEMENTAL SENIOR INDENTURE, dated as of November 25, 2019, by and among Teva Pharmaceutical Finance Netherlands III B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid), incorporated under Dutch law (the “Issuer”), Teva Pharmaceutical Industries Limited, a corporation incorporated under the laws of Israel (the “Guarantor”), and The Bank of New York Mellon, a New York banking corporation, as trustee (the “Trustee”).
TEVA PHARMACEUTICAL FINANCE NETHERLANDS II B.V., as Issuer, TEVA PHARMACEUTICAL INDUSTRIES LIMITED, as Guarantor, THE BANK OF NEW YORK MELLON, as Trustee and THE BANK OF NEW YORK MELLON, LONDON BRANCH, as Paying Agent SECOND SUPPLEMENTAL SENIOR...Second Supplemental Senior Indenture • November 25th, 2019 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
Contract Type FiledNovember 25th, 2019 Company Industry JurisdictionSECOND SUPPLEMENTAL SENIOR INDENTURE, dated as of November 25, 2019, by and among Teva Pharmaceutical Finance Netherlands II B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid), incorporated under Dutch law (the “Issuer”), Teva Pharmaceutical Industries Limited, a corporation incorporated under the laws of Israel (the “Guarantor”), The Bank of New York Mellon, a New York banking corporation, as trustee (the “Trustee”) and The Bank of New York Mellon, London Branch, as paying agent (the “Paying Agent”).